McKesson profit up 37%, helped by generic drugs
From Bloomberg News
November 1, 2006
Drug distributor McKesson Corp. said its fiscal second-quarter profit rose 37% as generic drugs helped cut costs and the company sold more computer systems. A gain on income-tax expense boosted earnings.
Net income for the quarter ended Sept. 30 rose to $229 million, or 75 cents a share, from $167 million, or 53 cents, a year earlier, San Francisco-based McKesson said. Revenue rose 5% to $22.4 billion. Profit beat analyst estimates.
ncreased sales of generic versions of drugs such as the blood thinner Plavix and the Medicare Part D prescription benefit for people 65 and older fueled demand at retail pharmacies, adding sales for drug distributors.
Sales of computers and information technology helped the company's performance, said Lisa Gill, a JPMorgan Securities Inc. analyst in New York .
Article source:- http://www.latimes.com/business/la-fi-calearns1.1nov01,1,3708001.story?coll=la-headlines-business
Important Note :The above information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. It should not be interpreted to indicate that use of the medication is safe, appropriate, or effective for you. Consult your healthcare professional before using any medicine.